http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008141680-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2008141680-A |
titleOfInvention | NEW COMPOSITIONS THAT STABILIZE IMMUNOGENIC COMPOSITIONS AND INHIBIT THEIR DEPOSITION |
abstract | 1. The composition stabilizing the polysaccharide-protein conjugate, wherein said composition contains (1) a buffered saline solution, the buffer having a pKa of from about 3.5 to about 7.5, (2) a surface-active agent, and (3) one or more polysaccharide-protein conjugates. ! 2. The composition according to claim 1, characterized in that the composition containing the polysaccharide-protein conjugate is in a container selected from one or more of the group consisting of a bottle, bottle stopper, bottle cover, glass cover, rubber cover, plastic cover , syringe, syringe plug, syringe piston, flask, beaker, graduated cylinder, fermenter, bioreactor, hose, tube, bag, jar, ampoule, bottle and disposable pen. ! 3. The composition according to claim 1, characterized in that said container is siliconized. ! 4. The composition according to claim 1, characterized in that the buffer contains succinate in a final concentration of from 1 to 10 mm and a pH of from 5.8 to 6.0. ! 5. The composition according to claim 1, characterized in that the surface-active agent is a polysorbate 80.! 6. The composition according to claim 5, characterized in that the final concentration of polysorbate 80 in the composition is at least from 0.01 to 10% wt./about. composition. ! 7. The composition according to claim 1, characterized in that the polysaccharide-protein conjugate contains one or more pneumococcus polysaccharides. ! 8. The composition according to claim 1, characterized in that it also contains one or more polysaccharides of meningococcus, one or more antigenic proteins of meningococcus or a combination of them! 9. The composition according to claim 1, characterized in that it also contains one or more streptococcal polysaccharides, one or more streptococcal antigenic proteins, or a combination thereof. ! 10. The composition according to claim 1, characterized in that the composition containing the polysaccharide-protein conjugate, � |
priorityDate | 2006-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.